Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Genflow Biosciences moves canine longevity study towards six-month data

Genflow Biosciences is progressing its canine longevity study towards six-month data after reporting encouraging early survival and safety observations...

August 18, 2026

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...

August 18, 2026

Verici Dx targets growing demand for kidney transplant diagnostics

Verici Dx is targeting the expanding kidney transplant diagnostics market as molecular surveillance becomes a larger part of post-transplant care...

August 18, 2026

AstraZeneca reports positive Phase III results for Tagrisso-Orpathys lung cancer combination

Astrazeneca Plc has reported positive SAFFRON Phase III results for Tagrisso and Orpathys, showing improved progression-free and overall survival...

August 17, 2026

Verici Dx strengthens commercial case for kidney transplant risk test

Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...

August 14, 2026

Healthspan becomes a bigger part of the healthy ageing debate

Healthspan is becoming a key part of the longevity discussion as attention shifts from simply living longer to staying healthier for more of those years...

August 11, 2026

EDX Medical positioned in growing prostate screening push

EDX Medical is positioned in the growing prostate screening debate as demand builds for more accurate, less invasive diagnostic testing...

August 11, 2026

Verici Dx secures Olink Certified Service Provider status

Verici Dx has achieved Olink Certified Service Provider status, expanding its proteomics assay capabilities at its CAP-certified and CLIA-accredited laboratory...

August 11, 2026

Pulmonary fibrosis care needs support a long-term treatment market

Pulmonary fibrosis creates long-term demand for treatments, respiratory equipment and patient-support services as care needs increase over time...

August 10, 2026

Precision medicine and rare disease development expand the targeted biotech opportunity

Precision medicine and rare disease development are creating more focused biotech opportunities built around biomarkers, targeted trials and clearly defined patient groups...

August 10, 2026

Biotech Growth secures major value from Forte Biosciences takeover

Biotech Growth is set to benefit from Argenx’s $2.2 billion acquisition of Forte Biosciences after entering the company at a much lower valuation...

August 5, 2026

Cizzle Biotechnology begins US commercial launch of lung cancer blood test

Cizzle Biotechnology has started the US commercial rollout of its CIZ1B lung cancer blood test through an initial launch in Texas...

August 5, 2026

Genflow nears key data readout for SIRT6 gene therapy platform

Genflow is nearing a key data point as it combines animal study results, specialist RNA delivery support and broader patent protection...

August 5, 2026

Verici Dx adds senior transplant experts to support clinical development

Verici Dx has expanded its Scientific Advisory Board with 14 senior transplant and clinical research specialists to support product development and adoption...

August 4, 2026

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...

August 4, 2026

Cizzle Bio signs second US laboratory agreement for lung cancer blood test

Cizzle Bio has partnered with BioBridge Global to validate and offer the CIZ1B Biomarker Blood Test through a CLIA-certified laboratory serving healthcare providers across South Texas...

August 3, 2026

Genflow Biosciences links ageing science with MASH research

MASH gives Genflow Biosciences a defined opportunity to explore how its SIRT6-based gene therapy research could address metabolic liver damage, inflammation and fibrosis...

August 3, 2026

EDX Medical Group deploys rapid pneumonia test at Addenbrooke’s ICU

EDX Medical Group has said its rapid pneumonia test is now in NHS clinical practice and has benefited patients at Addenbrooke's Hospital...

August 3, 2026

Genflow Biosciences advances SIRT6 patent portfolio in US and Europe

Genflow Biosciences has reported progress on its SIRT6 patent families, including a published US application and Track One examination...

August 3, 2026

Haleon reports half-year results and declares interim dividend

Haleon has announced its half-year results, declared a 2.4 pence interim dividend and provided details of its investor presentation...

July 30, 2026

News and Interview Alerts

Company Presentations

Poolbeg Pharma – Well Positioned for Success with CEO Jeremy Skillington

Time Finance Plc Q3 Results and Profit Upgrades with Ed Rimmer CEO (VIDEO)

Accrol Group Holdings Results Presentation 2024 (VIDEO)

Poolbeg Pharma A Strategic Vision, Pioneering the Future of Innovative Medicine

Q&As

Oriole Resources CEO Martin Rosser highlights high-grade Niambaram gold and wider Eastern CLP potential

21 August 2026

Arbuthnot Banking Group reports record deposits and wealth assets (LON:ARBB)

21 August 2026

Hardide CEO Matt Hamblin outlines growth strategy and capacity expansion

13 August 2026

Hercules CEO & CFO discuss new Power & Energy Services division

11 August 2026

Ilika: Stereax revenue growth and Goliath opportunities ahead

11 August 2026

Hardman & Co

ICG Enterprise Trust: Investor questions answered and 1HFY’27 results

14 October 2026

Neuberger Private Equity Partners Limited 1H’26 results: Foot on the accelerator

8 October 2026

Chesnara Plc: Acquisitions show immediate benefits

2 September 2026

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

4 August 2026

Real Estate Credit Investments maintains dividend as credit remains resilient

3 August 2026

Green News

Ferro-Alloy Resources appoints Peter Secker as CEO

26 October 2026

Ilika launches ORKA brand for deep-sea battery systems

22 October 2026

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

13 October 2026

Ampeak Energy Director Buys 500,000 shares in market purchase

6 October 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Real Estate Credit Investments — Three Routes Back to Dividend Cover (video)

Sintana Energy: Chevron’s Uruguay Seismic Push Keeps a 2028 Well in Sight (video)

Oriole Resources Mbe Gold Resource Jumps to 1.66 Million Ounces as District-Scale Potential Builds (video)

CMC Markets: Why Simpler Technology and Global Reach Could Drive Its Next Retail Growth Phase (video)

RM Plc Assessment Pipeline Doubles as RM Ava Opens New Growth Markets (video)

BrokerTalk

Norcros Delivers Solid First-Quarter Growth as Market Share Gains Continue, Shore Capital

31 July 2026

Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML)

30 July 2026

Hardide Plc FY26 EPS Forecast Raised 33% as Cavendish Lifts Target Price

22 July 2026

Pharos Energy reports high production, strong cash position and further Vietnam drilling progress, Auctus Advisors

20 July 2026

Avingtrans Raises £21 Million to Expand Its US Nuclear Opportunity, Cavendish

20 July 2026

Funds

Real Estate Credit Investments reports 10.5% dividend yield and £5m Spanish loan commitment

28 October 2026

City Natural Resources Growth and Income PLC

City Natural Resources Growth and Income reports 76.6% annual NAV return

28 October 2026

Volta Finance generates €38m in interest income with 1.8x dividend cover

22 October 2026

Geiger Counter highlights strong uranium market fundamentals and growing nuclear demand

21 October 2026

City Natural Resources Chairman Christopher Casey outlines Tufton’s investment strategy

21 October 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Ithaca Energy CEO Luciano Vasques to retire by March 2027

16 October 2026

Aviva targets £500m wealth operating profit by 2032

16 October 2026

JD Sports Senior Independent Director Kath Smith to step down in January 2027

16 October 2026

Balfour Beatty hosts investor event at Bramford to Twinstead power project

15 October 2026

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Evaluating a 20.73% Upside Potential in Packaged Foods

28 October 2026

Coats Group PLC (COA.L) Stock Analysis: Strong Buy Ratings and 45% Potential Upside

28 October 2026

Bellway PLC (BWY.L): An Investor’s Insight into Growth Potential with a 21% Revenue Surge

28 October 2026

Chemring Group PLC (CHG.L) Investor Outlook: Exploring a 14.74% Potential Upside in the Aerospace & Defense Sector

28 October 2026

Close Brothers Group PLC (CBG.L): Analyst Ratings Signal a 34.63% Potential Upside

28 October 2026

Health

Genflow Biosciences moves canine longevity study towards six-month data

Genflow Biosciences is progressing its canine longevity study towards six-month data after reporting encouraging early survival and safety observations...

August 18, 2026

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...

August 18, 2026

Verici Dx targets growing demand for kidney transplant diagnostics

Verici Dx is targeting the expanding kidney transplant diagnostics market as molecular surveillance becomes a larger part of post-transplant care...

August 18, 2026

AstraZeneca reports positive Phase III results for Tagrisso-Orpathys lung cancer combination

Astrazeneca Plc has reported positive SAFFRON Phase III results for Tagrisso and Orpathys, showing improved progression-free and overall survival...

August 17, 2026

Verici Dx strengthens commercial case for kidney transplant risk test

Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...

August 14, 2026

Healthspan becomes a bigger part of the healthy ageing debate

Healthspan is becoming a key part of the longevity discussion as attention shifts from simply living longer to staying healthier for more of those years...

August 11, 2026

EDX Medical positioned in growing prostate screening push

EDX Medical is positioned in the growing prostate screening debate as demand builds for more accurate, less invasive diagnostic testing...

August 11, 2026

Verici Dx secures Olink Certified Service Provider status

Verici Dx has achieved Olink Certified Service Provider status, expanding its proteomics assay capabilities at its CAP-certified and CLIA-accredited laboratory...

August 11, 2026

Pulmonary fibrosis care needs support a long-term treatment market

Pulmonary fibrosis creates long-term demand for treatments, respiratory equipment and patient-support services as care needs increase over time...

August 10, 2026

Precision medicine and rare disease development expand the targeted biotech opportunity

Precision medicine and rare disease development are creating more focused biotech opportunities built around biomarkers, targeted trials and clearly defined patient groups...

August 10, 2026

Biotech Growth secures major value from Forte Biosciences takeover

Biotech Growth is set to benefit from Argenx’s $2.2 billion acquisition of Forte Biosciences after entering the company at a much lower valuation...

August 5, 2026

Cizzle Biotechnology begins US commercial launch of lung cancer blood test

Cizzle Biotechnology has started the US commercial rollout of its CIZ1B lung cancer blood test through an initial launch in Texas...

August 5, 2026

Genflow nears key data readout for SIRT6 gene therapy platform

Genflow is nearing a key data point as it combines animal study results, specialist RNA delivery support and broader patent protection...

August 5, 2026

Verici Dx adds senior transplant experts to support clinical development

Verici Dx has expanded its Scientific Advisory Board with 14 senior transplant and clinical research specialists to support product development and adoption...

August 4, 2026

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...

August 4, 2026

Cizzle Bio signs second US laboratory agreement for lung cancer blood test

Cizzle Bio has partnered with BioBridge Global to validate and offer the CIZ1B Biomarker Blood Test through a CLIA-certified laboratory serving healthcare providers across South Texas...

August 3, 2026

Genflow Biosciences links ageing science with MASH research

MASH gives Genflow Biosciences a defined opportunity to explore how its SIRT6-based gene therapy research could address metabolic liver damage, inflammation and fibrosis...